Politico October 2, 2024
FOLLOW THE MONEY
Artificial intelligence’s big promise in medicine is that it could help doctors diagnose diseases sooner than traditional methods.
It could also hit patients in the pocketbook.
A group of Stanford University professors warns in The New England Journal of Medicine that insurers aren’t yet on board with covering tests recommended by new AI tools.
The professors envision an increasing number of scenarios in which AI tools identify possible disease and recommend further testing — only to have insurers refuse to pay absent traditional signs or symptoms of a condition.
Why it matters: Without alignment of the financial and medical benefits of the technology, some early-detection tools could be difficult to sell to health systems — and may...
Today's Sponsors
Today's Sponsor